Navigation Links
Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing
Date:5/18/2009

and innate immunity."

Commenting on today's announcement John O'Dea, Head of Lifesciences in the High Potential Start Up department in Enterprise Ireland said: "Opsona epitomises the type of innovative high potential company that EI is keen to support, and shows what can be achieved when the ambition and energy of a company are harnessed and supported. The company has a solid business strategy and strong links with industry and universities. Opsona has grown its product pipeline by investing intensively in collaborative R & D."

Notes to Editors:

About Opsona Therapeutics - Opsona is a drug development company, focused on novel therapeutic and preventative approaches to autoimmune and inflammatory diseases. The company was founded in 2004 by three of Trinity College Dublin's respected Immunologists. Opsona has a pipeline of therapeutics in advanced pre-clinical development which modulate the innate immune system, including biologics and small molecules. Opsona's lead product, a fully humanized monoclonal antibody (OPN-305) has demonstrated efficacy in a number of animal models and will start pivotal clinical trials in 2010. The company has also signed significant partnering and collaborative deals, with companies like Wyeth (USA). Headquartered in Dublin, Opsona also has laboratories in Lausanne, Switzerland. http://www.opsona.com

About Roche Venture Fund - The Roche Venture Fund makes investments in early stage biotech and diagnostics companies to support innovative technologies and medicines. Based in Basel, Switzerland, the Roche Venture Fund manages a portfolio of over 30 companies in 10 countries. http://www.venturefund.roche.com

About Enterprise Ireland - Enterprise Ireland is the government agency responsible for the development of Irish industry.
'/>"/>

SOURCE Opsona Therapeutics Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes
2. Codexis R&D Productivity Panels Also Used By Roche
3. Roche Madison Moves to New Facility
4. BioDuro and Roche Expand Strategic Collaboration to Provide Drug Discovery Services
5. Roche to Introduce New LightCycler(R) MRSA Advanced Test in the EU
6. Roche Completes Tender Offer for Genentech
7. Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation
8. SD Canada Announces CE Mark for ThyroChek(R) Adult and NeoNatal Tests
9. Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
10. Roche Intends to Commence Tender Offer to Acquire All Shares of Genentech for US$ 86.50 Per Share in Cash
11. Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Stem cell-enriched autologous fat enables sustainable breast augmentation ... the media: For years a French company has been ... cause cancer. More than 100,000 women worldwide must now ... or carrying a "time bomb" in their bodies. Stem ...
... Biotherapeutics (OTC.BB: NWBO) (NW Bio) today announced that it will ... the Windsor Room of the Sir Francis Drake Hotel as ... emerging biotech companies held over 3 days this week in ... attendees are expected to be listening to presentations by up ...
... SEATTLE, Jan. 10, 2012  Omeros Corporation (NASDAQ: OMER ... selectively with each of GPR25, GPR32, GPR80, GPR135 and MAS1, ... unlocked by Omeros to 23, representing 30 percent of the ... unlocked by Omeros for drug development equals half of the ...
Cached Biology Technology:Silicone Scandal: Stem Cell Breast Augmentation a Safe Alternative 2NW Bio to Present Today at the OneMedForum SF 2012 Conference 2NW Bio to Present Today at the OneMedForum SF 2012 Conference 3Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 2Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 3Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 4Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 5
(Date:4/15/2014)... research published in the March/April 2014 issue of ... shows whey protein, either as a supplement combined ... or weight-maintenance diet, may provide men and women benefits ... 14 randomized controlled trials with a total of 626 ... that used whey protein to replace calories in the ...
(Date:4/14/2014)... Rican climate over the past three decades have caused ... territory,s national animal. UCLA biologists have found that not ... call has also become shorter and higher pitched. ... of integrative biology and physiology and of ecology and ... the study examined 170 male coqui frogs ( Eleutherodactylus ...
(Date:4/14/2014)... the International Space Station inside the Dragon capsule ... in-orbit food production capabilities in more ways than ... for granted, fresh food. , NASA,s Veg-01 experiment ... and performance of a new expandable plant growth ... investigation will focus on the growth and development ...
Breaking Biology News(10 mins):New meta-analysis builds on the power of whey protein for improved body composition 2New meta-analysis builds on the power of whey protein for improved body composition 3Climate change a likely culprit in coqui frog's altered calls, say UCLA biologists 2Veggie will expand fresh food production on space station 2
... -- Dangerous disease often spreads faster than it takes ... researchers at Kansas State University have developed a test ... Sanjeev Narayanan, assistant professor, and Greg Peterson, research ... pathobiology, use a device called a DNA spotted microarray ...
... Ackermann and Wolf-Dietrich Hardt, in collaboration with Michael Doebeli ... have been able to describe how random molecular processes ... a self-destructive act to generate a greater common good, ... Survival strategy The biologists investigated this ...
... relapse after renewed drug administration are typical behavioral patterns ... the brain,s reward center are directly responsible for this. ... the Institute of Mental Health (ZI) in Mannheim, the ... University of Geneva, Switzerland, in the latest issue of ...
Cached Biology News:Rapid test for pathogens developed by K-State researchers 2ETH Zurich study on salmonella self-destruction 2ETH Zurich study on salmonella self-destruction 3Cocaine: How addiction develops 2
Anti-ACTH Immunogen: Porcine ACTH conjugated to BSA. Available Date: 38566...
Goat polyclonal to BACE1 ( Abpromise for all tested applications). entrezGeneID: 23621 SwissProtID: P56817...
... Immunogen: Peptide ... encompassing the human, mouse, and ... Accession Number: NM_000314 ... Routinely evaluated by immunoblot. ...
Mouse monoclonal [MN-8C4] to zona radiata ( Abpromise for all tested applications). Antigen: Purified eggshell proteins (zona radiata proteins and small amounts of zona pellucida proteins) from ...
Biology Products: